JAGX
Price
$8.06
Change
+$1.39 (+20.84%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
5.43M
WXIBF
Price
$2.74
Change
+$0.32 (+13.22%)
Updated
Apr 14 closing price
Capitalization
11.93B
Ad is loading...

JAGX vs WXIBF

Header iconJAGX vs WXIBF Comparison
Open Charts JAGX vs WXIBFBanner chart's image
Jaguar Health
Price$8.06
Change+$1.39 (+20.84%)
Volume$200
Capitalization5.43M
Wuxi Biologics Cayman
Price$2.74
Change+$0.32 (+13.22%)
Volume$5.4K
Capitalization11.93B
JAGX vs WXIBF Comparison Chart
Loading...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JAGX vs. WXIBF commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAGX is a Buy and WXIBF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (JAGX: $8.06 vs. WXIBF: $2.74)
Brand notoriety: JAGX and WXIBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAGX: 125% vs. WXIBF: 195%
Market capitalization -- JAGX: $5.43M vs. WXIBF: $11.93B
JAGX [@Biotechnology] is valued at $5.43M. WXIBF’s [@Biotechnology] market capitalization is $11.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAGX’s FA Score shows that 1 FA rating(s) are green whileWXIBF’s FA Score has 2 green FA rating(s).

  • JAGX’s FA Score: 1 green, 4 red.
  • WXIBF’s FA Score: 2 green, 3 red.
According to our system of comparison, WXIBF is a better buy in the long-term than JAGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAGX’s TA Score shows that 5 TA indicator(s) are bullish.

  • JAGX’s TA Score: 5 bullish, 3 bearish.

Price Growth

JAGX (@Biotechnology) experienced а +46.28% price change this week, while WXIBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

JAGX is expected to report earnings on Mar 31, 2025.

WXIBF is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXIBF($11.9B) has a higher market cap than JAGX($5.43M). WXIBF has higher P/E ratio than JAGX: WXIBF (25.69) vs JAGX (0.01). WXIBF YTD gains are higher at: 26.267 vs. JAGX (-68.079). WXIBF has higher annual earnings (EBITDA): 5.5B vs. JAGX (-29.1M). WXIBF has higher revenues than JAGX: WXIBF (17B) vs JAGX (10.5M).
JAGXWXIBFJAGX / WXIBF
Capitalization5.43M11.9B0%
EBITDA-29.1M5.5B-1%
Gain YTD-68.07926.267-259%
P/E Ratio0.0125.690%
Revenue10.5M17B0%
Total Cash13.3MN/A-
Total Debt34.3MN/A-
FUNDAMENTALS RATINGS
JAGX vs WXIBF: Fundamental Ratings
JAGX
WXIBF
OUTLOOK RATING
1..100
2999
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9916
PRICE GROWTH RATING
1..100
6548
P/E GROWTH RATING
1..100
10011
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JAGX's Valuation (15) in the Pharmaceuticals Generic industry is somewhat better than the same rating for WXIBF (70) in the null industry. This means that JAGX’s stock grew somewhat faster than WXIBF’s over the last 12 months.

JAGX's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as WXIBF (100) in the null industry. This means that JAGX’s stock grew similarly to WXIBF’s over the last 12 months.

WXIBF's SMR Rating (16) in the null industry is significantly better than the same rating for JAGX (99) in the Pharmaceuticals Generic industry. This means that WXIBF’s stock grew significantly faster than JAGX’s over the last 12 months.

WXIBF's Price Growth Rating (48) in the null industry is in the same range as JAGX (65) in the Pharmaceuticals Generic industry. This means that WXIBF’s stock grew similarly to JAGX’s over the last 12 months.

WXIBF's P/E Growth Rating (11) in the null industry is significantly better than the same rating for JAGX (100) in the Pharmaceuticals Generic industry. This means that WXIBF’s stock grew significantly faster than JAGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JAGX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CATO2.480.08
+3.33%
CATO Corp
GSAT19.550.45
+2.36%
Globalstar Inc
UDR41.800.26
+0.63%
UDR
PNTG25.25N/A
N/A
Pennant Group (The)
TRNR0.72-0.06
-7.13%
Interactive Strength Inc

JAGX and

Correlation & Price change

A.I.dvisor tells us that JAGX and HEPA have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JAGX and HEPA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
+20.84%
HEPA - JAGX
29%
Poorly correlated
+2.11%
SRPT - JAGX
28%
Poorly correlated
+3.82%
DVHGF - JAGX
27%
Poorly correlated
N/A
AFMD - JAGX
26%
Poorly correlated
+15.54%
SNPX - JAGX
26%
Poorly correlated
+1.32%
More

WXIBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, WXIBF has been loosely correlated with WXXWY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if WXIBF jumps, then WXXWY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXIBF
1D Price
Change %
WXIBF100%
N/A
WXXWY - WXIBF
46%
Loosely correlated
+2.03%
JAGX - WXIBF
22%
Poorly correlated
+20.84%
NVAX - WXIBF
21%
Poorly correlated
-5.35%
ELVAF - WXIBF
21%
Poorly correlated
N/A
EVAX - WXIBF
20%
Poorly correlated
+6.71%
More